The global IVF devices & consumables market is anticipated to show significant growth during the forecast period, owing to rise in infertility rate, increase in trend of delayed pregnancies, surge in awareness of IVF, and technological advancements in IVF devices. Furthermore, increase in number of same sex marriages and upsurge in disposable income considerably contribute toward the market growth. However, higher cost, ethical issues and complications associated with IVF hamper the market growth.
The global IVF devices & consumables market is segmented based on product, technology, end user, and region. Based on product, the market is classified into instrument, accessory & disposable, and reagent & media. The instrument segment is further divided into sperm separation system, cryosystem, incubator, imaging system, ovum aspiration pump, cabinet, micromanipulator, and others. Reagent & media is subsegmented into cryopreservation media, semen processing media, ovum processing media, and embryo culture media.
According to technology, the market is categorized into fresh embryo IVF, frozen embryo IVF, and donor egg IVF. Depending on end user, it is divided into fertility clinic, hospital, surgical center, and clinical research institute. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
- A comprehensive IVF devices and consumables market analysis of all the geographical regions is provided to determine the prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
By Product
- Instrument
o Cryosystem
o Incubator
o Imaging System
o Ovum Aspiration Pump
o Cabinet
o Micromanipulator
o Others
- Accessory & Disposable
- Reagent & Media
o Semen Processing Media
o Ovum Processing Media
o Embryo Culture Media
By Technology Type
- Fresh Embryo IVF
- Frozen Embryo IVF
- Donor Egg IVF
- Fertility Clinic
- Hospital
- Surgical Center
- Clinical Research Institute
- North America
o Canada
o Mexico
- Europe
o France
o UK
o Italy
o Spain
o Rest of Europe
- Asia-Pacific
o China
o Australia
o India
o Rest of Asia-Pacific
- LAMEA
o Middle East
o Africa
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- Cook Medical Inc.
- Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)
- Genea Biomedx
- Merck KGaA (EMD Serono, Inc.)
- Millendo Therapeutics, Inc.
- Oxford Gene Technology
- Progyny Inc.
- The Cooper Companies, Inc. (CooperSurgical, Inc.)
- Thermo Fisher Scientific, Inc.
- Vitrolife AB
- Esco Micro Pte Ltd.
- IVFtech ApS
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Alternative technologies
3.2.1. Intrauterine insemination (IUI) technique
3.2.1.1. Benefits of IUI
3.2.1.2. Difference between IUI and IVF techniques
3.2.2. Gamete intra-fallopian transfer (GIFT) technique
3.2.2.1. Differences between GIFT and IVF technique
3.2.3. Zygote intrafallopian transfer (ZIFT) technique
3.2.3.1. Differences between ZIFT and IVF technique
3.3. Replacing IVF Procedures By Fertility Drugs And Surgeries
3.3.1. Female infertility treatments
3.3.2. Risks associated with fertility drugs
3.3.3. Male infertility treatment
3.4. Cost Of IVF Procedures
3.5. Role of Donors In The IVF Market
3.5.1. Egg donation
3.5.2. Egg sharing
3.5.3. Sperm donation
3.5.4. Embryo donation/adoption
3.5.5. Donation for research
3.6. Surrogacy
3.6.1. Legal issues
3.7. IVF Trends In Same Sex Couples
3.7.1. Artificial insemination
3.7.2. Surrogate mothers
3.7.3. In vitro fertilization
3.8. Advanced IVF Technologies
3.8.1. Capsule IVF
3.8.2. Three parent IVF
3.8.2.1. Ethical concerns
3.8.3. Mini IVF
3.8.3.1. Advantages
3.8.3.2. Drawbacks
3.8.4. Embryo scope
3.8.4.1. Advantages
3.8.4.2. PICSI
3.9. Fertility Treatment And Gender Selection
3.9.1. Methods of sex selection
3.9.1.1. Gradient method
3.9.1.2. Flow cytometry technique
3.9.1.3. Pre-implantation genetic diagnosis (PGD)
3.9.1.3.1. Ethical and legal issues
3.10. Metabolomics In Embryo Screening Methods
3.11. Application Of Stem Cells In IVF
3.12. IVF And Resource-Poor Countries
3.13. Key Findings
3.13.1. Top impacting factors
3.13.2. Top investment pockets
3.13.3. Top winning strategies
3.14. Porter’s Five Forces Analysis
3.14.1. High competition reduces the power of suppliers
3.14.2. Scattered nature and large count of end users regulates the buyer power moderately
3.14.3. High capital cost lowers the threat of new entrants
3.14.4. Industry rivalry is intense due to presence of few dominant competitors
3.14.5. Lack of efficient substitutes lowers the threat from substitutes
3.15. Value Chain Analysis
3.16. Patent Analysis
3.16.1. Patent analysis, by year
3.16.2. Patents analysis, by country
3.17. Regulatory Issues And Legislations
3.18. Insurance Reimbursement Scenario
3.19. Clinical Trial
3.20. Drivers
3.20.1. Delayed pregnancies in women
3.20.2. Increase in global infertility rates
3.20.3. Technological advancement in IVF devices
3.20.4. Increase in gamete donations
3.20.5. Increase in disposable income
3.20.6. Increase in success rates
3.20.7. Surge in healthcare expenditure worldwide
3.21. Restraints
3.21.1. Cost constraints
3.21.2. Complications associated with IVF treatment
3.21.3. Low awareness level
3.22. Opportunities
3.22.1. Fertility tourism
3.22.2. Growth opportunities in the emerging markets
3.22.3. Increase in number of fertility clinics
3.22.4. Rise in same sex marriages
3.23. Impact analyses
Chapter: 4: IVF DEVICES AND CONSUMABLES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Instruments
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type
4.2.2.1. Sperm separation system
4.2.2.1.1. Market size and forecast
4.2.2.2. Cryosystem
4.2.2.2.1. Market size and forecast
4.2.2.3. Incubator
4.2.2.3.1. Market size and forecast
4.2.2.4. Imaging system
4.2.2.4.1. Market size and forecast
4.2.2.5. Ovum aspiration pump
4.2.2.5.1. Market size and forecast
4.2.2.6. Cabinet (workstation)
4.2.2.6.1. Market size and forecast
4.2.2.7. Micromanipulator system
4.2.2.7.1. Market size and forecast
4.2.2.8. Others
4.2.2.8.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. Accessories & disposables
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Reagent & media
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by type
4.4.2.1. Cryopreservation media
4.4.3. Different media used in cryopreservation procedures include the following:
4.4.3.1. Market size and forecast
4.4.3.2. Semen processing media
4.4.3.2.1. Market size and forecast
4.4.3.3. Ovum processing media
4.4.3.3.1. Market size and forecast
4.4.3.4. Embryo culture media
4.4.3.4.1. Market size and forecast
4.4.4. Market size and forecast, by region
4.4.5. Market analysis, by country
Chapter: 5: IVF DEVICES AND CONSUMABLES MARKET, BY TECHNOLOGY
5.1. Overview
5.1.1. Market size and forecast
5.2. Fresh Embryo IVF
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Frozen Embryo IVF
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Donor Embryo IVF
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
Chapter: 6: IVF DEVICES AND CONSUMABLES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Fertility Clinics
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Hospitals
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Surgical Centers
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Clinical Research Institutes
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
Chapter: 7: IVF DEVICES AND CONSUMABLES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.1.2. IVF devices and consumables market, quarterly update , 2019
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. IVF devices and consumables market, by product
7.2.2.1.2. U.S. IVF devices and consumables market, by technology
7.2.2.1.3. U.S. IVF devices and consumables market, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada IVF devices and consumables market, by product
7.2.2.2.2. Canada IVF devices and consumables market, by technology
7.2.2.2.3. Canada IVF devices and consumables market, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico IVF devices and consumables market, by product
7.2.2.3.2. Mexico IVF devices and consumables market, by technology
7.2.2.3.3. Mexico IVF devices and consumables market, by end user
7.2.3. North America IVF devices and consumables market, by product
7.2.4. North America IVF devices and consumables market, by technology
7.2.5. North America IVF devices and consumables market, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany IVF devices and consumables market, by product
7.3.2.1.2. Germany IVF devices and consumables market, by technology
7.3.2.1.3. Germany IVF devices and consumables market, by end user
7.3.2.2. France
7.3.2.2.1. France IVF devices and consumables market, by product
7.3.2.2.2. France IVF devices and consumables market, by technology
7.3.2.2.3. France IVF devices and consumables market, by end user
7.3.2.3. UK
7.3.2.3.1. UK IVF devices and consumables market, by product
7.3.2.3.2. UK IVF devices and consumables market, by technology
7.3.2.3.3. UK IVF devices and consumables market, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy IVF devices and consumables market, by product
7.3.2.4.2. Italy IVF devices and consumables market, by technology
7.3.2.4.3. Italy IVF devices and consumables market, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain IVF devices and consumables market, by product
7.3.2.5.2. Spain IVF devices and consumables market, by technology
7.3.2.5.3. Spain IVF devices and consumables market, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe IVF devices and consumables market, by product
7.3.2.6.2. Rest of Europe IVF devices and consumables market, by technology
7.3.2.6.3. Rest of Europe IVF devices and consumables market, by end user
7.3.3. Europe IVF devices and consumables market, by product
7.3.4. Europe IVF devices and consumables market, by technology
7.3.5. Europe IVF devices and consumables market, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan IVF devices and consumables market, by product
7.4.2.1.2. Japan IVF devices and consumables market, by technology
7.4.2.1.3. Japan IVF devices and consumables market, by end user
7.4.2.2. China
7.4.2.2.1. China IVF devices and consumables market, by product
7.4.2.2.2. China IVF devices and consumables market, by technology
7.4.2.2.3. China IVF devices and consumables market, by end user
7.4.2.3. Australia
7.4.2.3.1. Australia IVF devices and consumables market, by product
7.4.2.3.2. Australia IVF devices and consumables market, by technology
7.4.2.3.3. Australia IVF devices and consumables market, by end user
7.4.2.4. India
7.4.2.4.1. India IVF devices and consumables market, by product
7.4.2.4.2. India IVF devices and consumables market, by technology
7.4.2.4.3. India IVF devices and consumables market, by end user
7.4.2.5. Rest of Asia-Pacific
7.4.2.5.1. Rest of Asia-Pacific IVF devices and consumables market, by product
7.4.2.5.2. Rest of Asia-Pacific IVF devices and consumables market, by technology
7.4.2.5.3. Rest of Asia-Pacific IVF devices and consumables market, by end user
7.4.3. Asia-Pacific IVF devices and consumables market, by product
7.4.4. Asia-Pacific IVF devices and consumables market, by technology
7.4.5. Asia-Pacific IVF devices and consumables market, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Latin America
7.5.2.1.1. Latin American IVF devices and consumables market, by product
7.5.2.1.2. Latin American IVF devices and consumables market, by technology
7.5.2.1.3. Latin American IVF devices and consumables market, by end user
7.5.2.2. Middle East
7.5.2.2.1. Middle East IVF devices and consumables market, by product
7.5.2.2.2. Middle East IVF devices and consumables market, by technology
7.5.2.2.3. Middle East IVF devices and consumables market, by end user
7.5.2.3. Africa
7.5.2.3.1. Africa IVF devices and consumables market, by product
7.5.2.3.2. Africa IVF devices and consumables market, by technology
7.5.2.3.3. Africa IVF devices and consumables market, by end user
7.5.3. LAMEA IVF devices and consumables market, by product
7.5.4. LAMEA IVF devices and consumables market, by technology
7.5.5. LAMEA IVF devices and consumables market, by end user
Chapter: 8: COMPANY PROFILES
8.1. Cook Medical Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. SWOT analysis
8.2. The Cooper Companies, Inc. (CooperSurgical, Inc.)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.2.7. SWOT analysis
8.3. Merck KGaA (EMD Serono, Inc.)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Product portfolio
8.3.6. Key strategic moves and developments
8.3.7. SWOT analysis
8.4. Genea Biomedx
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Product portfolio
8.4.4. Key strategic moves and developments
8.4.5. SWOT analysis
8.5. Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.5.7. SWOT analysis
8.6. Millendo Therapeutics, Inc.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Key strategic moves and developments
8.6.6. SWOT analysis
8.7. Oxford Gene Technology
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments
8.7.6. SWOT analysis
8.8. Progyny Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.8.5. SWOT analysis
8.9. Thermo Fisher Scientific Inc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. SWOT analysis
8.10. Vitrolife AB
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
8.10.7. SWOT analysis
According to this report titled 'IVF Devices and Consumables Market, by Product, Technology, and End User: Global Opportunity Analysis and Industry Forecast, 2019 - 2026', the global IVF devices and consumables market size was valued at $2,243 million in 2018, and is expected to reach $7,732 million by 2026, growing at a CAGR of 16.6% from 2019 to 2026.
In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely used treatments, which assists couples with infertility problems, single mothers, and the LGBT community to procreate. Increase in infertility rate, rise in awareness toward IVF, growth in demand for advanced IVF technologies, and surge in IVF success rate are the key factors that drive the growth of the IVF devices and consumables market globally. However, the market growth is restricted by higher costs associated with IVF devices and ethical issues & complications associated with IVF.
Based on product, the accessory & disposable segment is the major revenue contributor, and is expected to dominate the market during the forecast period, due to their cost-effectiveness. However, the instrument segment is anticipated to grow at the highest rate, due to technological advancements and surge in demand for advanced IVF devices.
Based on technology, fresh embryo IVF is the major revenue contributor, and is expected to show dominance during the forecast period, due to its advantages such as higher success rate, convenience, cost-effectiveness, and safety.
Depending on end user, the global IVF devices and consumables market is dominated by the fertility clinic segment, and this trend is likely to continue during the forecast period, due to low cost of treatment and increase in number of fertility clinics. However, the surgical center segment is expected to grow at a significant rate, due to increase in number of surgery centers in developing regions and rise in use of IVF.
Key Findings of the IVF Devices and Consumables Market:
- The IVF devices and consumables market trends are analyzed through different verticals such as product, technology and end user in the report
- Based on product, the instrument segment is expected to experience rapid growth in the market, and is projected to grow at a CAGR of 20.4% from 2019 to 2026.
- By technology type, the fresh embryo IVF segment exhibits fastest growth, and is expected to register a CAGR of 17.0% from 2019 to 2026.
- Depending on end user, the fertility clinic segment held more than half share of the global market share in 2018, and is expected to remain dominant throughout the forecast period.
- Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 18.6% during the forecast period.
Europe accounted for nearly one-third share of the global market in 2018, and is expected to remain dominant throughout the forecast period, owing to higher demand for IVF, increase in infertile population, higher number of trained medical professionals, and availability of technological advance IVF devices with higher success rate. However, Asia-Pacific is expected to register highest CAGR during the forecast period majorly due to increase in disposable income and surge in adoption of IVF, owing to rise in infertility rate.
Key players in the IVF devices and consumables market have adopted various developmental strategies such as business expansion, merger & acquisition, and product developments to strengthen their foothold in the market. For instance, in July 2017, Fujifilm Holdings Corporation launched the Continuous Single Culture-NX, a next generation culture medium for embryos. This media culture has lower lactate concentration, which helps to maintain metabolic rates efficiently in the embryo culture for in vitro fertilization (IVF) applications. Similarly, in June 2016, Vitrolife AB launched the EmbryoScope+, an additional high-quality time-lapse system for undisturbed culture and improved selection of embryos. This product launch improved the IVF portfolio of the company. Furthermore, with respect to mergers, in December 2018, Milendo Therapeutics Inc. announced the successful merger completion of Ovascience. The combined company will operate under the name Millendo Therapeutics and will work toward development of Millendos leading orphan endocrine pipeline.
The key players profiled in this report include Cook Medical Inc., Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.), Genea Biomedx, Merck KGaA (EMD Serono, Inc.), Millendo Therapeutics, Inc., Oxford Gene Technology, Progyny Inc., The Cooper Companies, Inc. (CooperSurgical, Inc.), Thermo Fisher Scientific, Inc., and Vitrolife AB. The other companies included in the value chain analysis (but not included in the report) are Esco Micro Pte Ltd. and IVFtech ApS.
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
